Skip to content

BillionToOne, Inc. BLLN Change in fair value of term loan

Change in fair value of term loan at other companies

Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$1.47M-3.9%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$32K-87.5%
GeneDx Holdings logo
GeneDx HoldingsWGS
$2.54M+331%
Atlanticus Holdings Corporation logo
Atlanticus Holdings CorporationATLC
-$365.52M-105%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$0-100%
Enova International logo
Enova InternationalENVA
$346.18M+8.4%

Other financials

Income statement

See full
Revenue$108.4M+83.8%
Gross profit$79.1M+108%
Operating income$17.8M+870%
Net income$18.0M+551%
EPS (diluted)$0.34+187%

Balance sheet

See full
Cash & equivalents$537.5M+181%
Total debt$144.2M
Total equity$505.6M+300%
Total assets$700.7M

Cash flow

See full
Operating cash flow$15.4M+488%
CapEx$4.5M+90.5%
Free cash flow$11.0M+3,842%

Valuation

See full
Market cap$4.96B

Profitability

See full
Gross margin70.4%
Operating margin-96.9%
Net margin8.4%
FCF margin-83.4%

Returns & leverage

See full
Debt / equity0.3×
Current ratio10.9×

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept blln:FairValueAdjustmentOfTermLoanIncludingInterest.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's change in fair value of term loan.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BillionToOne, Inc. 's change in fair value of term loan?
BillionToOne, Inc. (BLLN) reported change in fair value of term loan of -$4.26M in Q1 2026.
How has BillionToOne, Inc. 's change in fair value of term loan changed year-over-year?
BillionToOne, Inc. 's change in fair value of term loan decreased by 37.8% year-over-year, from -$3.09M to -$4.26M.
What does change in fair value of term loan mean?
This metric represents the non-cash gain or loss resulting from the periodic revaluation of term loan obligations to their current fair market value. It reflects changes in market conditions, such as interest rate fluctuations or credit spreads, that impact the carrying value of debt instruments. Investors monitor this to isolate non-operating volatility from core operational performance.